High salt intake and cardiovascular disease: Is there a connection?

Nutrition

Volumn 16, Issue 7-8, 2000, Pages 662-664

  Chrysant, George S ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; NUTRITION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SALT INTAKE; SODIUM RESTRICTION;

CARDIOVASCULAR DISEASES; DIET, SODIUM-RESTRICTED; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; RENIN; RISK FACTORS; SODIUM CHLORIDE, DIETARY;

EID: 0034234704     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(00)00355-5     Document Type: Conference Paper

References (58)

1. Dahl L.K. Salt and hypertension. Am J Clin Nutr. 25:1972;23.
2. Gleibermann L. Blood pressure and dietary salt in human populations. Ecol Food Nutr. 2:1973;143.
3. Hunt J.C. Sodium intake and hypertension a cause for concern . Ann Intern Med. 98:1983;724.
4. Page L.B., Damon A., Moellering R. Jr. Antecedents of cardiovascular disease in six Solomon Islands societies. Circulation. 49:1974;1132.
5. Morgan T., Nowson C. The role of sodium restriction in the management of hypertension. Can J Physiol Pharmacol. 64:1986;786.
6. Freis E.D. Salt, volume, and the prevention of hypertension. Circulation. 53:1976;383.
7. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24-hour urinary sodium and potassium excretion. Br Med J 198;297:319.
8. Smith W.C.S., Combie I.K., Tavendale R.T., et al. Urinary electrolyte excretion, alcohol consumption, and blood pressure in the Scottish Heart Health Study. Br Med J. 297:1988;329.
9. Cutler J.A., Follman D., Allender P.S. Randomized trials of sodium reduction. An overview. Am J Clin Nutr. 65:1997;643S.
10. Cook N.R., Cohen J., Hebert P.R., et al. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 155:1995;701.
11. Graudal N.A., Galloe A.M., Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterol and triglycerides. JAMA. 279:1998;1383.
12. The effects of non-pharmacological interventions on blood pressure of persons with high normal levels. Results of the Trials of Hypertension Prevention (Phase 1). JAMA. 267:1992;1213.
13. Hebert PR, Bolt RJ, Borhani NO, et al., for the Trials of Hypertension Prevention (TOHP) Collaborative Research Group. Design of a multicenter trial to evaluate long-term lifestyle intervention in adults with high normal blood pressure levels: Trials of Hypertension Prevention (Phase II). Ann Epidemol 1995;5:130.
14. Effect of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high normal blood pressure the Trials of Hypertension Prevention, Phase II . Arch Intern Med. 157:1997;657.
15. Chrysant S.G., Weir M.R., Weder A.B., et al. There are no racial, age, sex or weight differences in the effect of salt on blood pressure in salt-sensitive hypertensive patients. Arch Intern Med. 157:1997;2489.
16. Weinberger M.H., Miller J.Z., Luft F.C., Grim C.E., Fineberg N.S. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 8:(suppl II):1986;127.
17. Weinberger M.H. Salt sensitivity of blood pressure in humans. Hypertension. 27:1996;481.
18. Sullivan J.M., Ratts T.E. Sodium sensitivity in human subjects hemodynamic and metabolic correlates . Hypertension. 11:1988;17.
19. Luft F.C., Miller J.Z., Grim C.E., et al. Salt sensitivity and resistance of blood pressure age and race as factors in physiological responses . Hypertension. 17:(suppl 1):1991;102.
20. Grim C.E., Luft F.C., Miller J.Z. Racial differences in blood pressure in Evans County Georgia relationship to sodium and potassium intake and plasma renin activity . J Chronic Dis. 33:1980;87.
21. Sowers J.R., Zemel M.D., Zemel L.P., et al. Salt sensitivity in blacks salt intake and natriuretic substances . Hypertension. 12:1988;485.
22. Law M.R., Frost C.D., Walk N.J. By how much does dietary salt reduction lower blood pressure analysis of observational data among populations . Br Med J. 302:1991;811.
23. Gillum R.J., Prineas R.J., Jeffery R.W. Non-pharmacologic therapy of hypertension the independent effects of weight reduction and sodium restriction in overweight borderline hypertensive patients . Am Heart J. 105:1983;128.
24. Rocchini A.P., Key J., Bondie D., et al. The effects of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med. 321:1989;580.
25. Myers J., Morgan T. The effects of sodium intake on the blood pressure related to age and sex. Clin Exp Hypertens. 5:1983;99.
26. Elliott P. Observational studies of salt and blood pressure. Hypertension. 17:(suppl I):1991;3.
27. Chrysant S.G., Danisa K., Kem D.C., et al. Racial differences in pressure, volume and renin interrelationships in essential hypertension. Hypertension. 1:1979;136.
28. Fujita T., Henry W.L., Bartter F.C., et al. Factors influencing blood pressure in salt sensitive patients with hypertension. Am J Med. 69:1980;334.
29. Campese V.M., Romoff M.S., Levitan D., et al. Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int. 21:1982;371.
30. Koolen M.I., Van Brummelen P.V. Adrenergic activity and peripheral hemodynamics in relation to sodium sensitivity in patients with essential hypertension. Hypertension. 6:1984;820.
31. Mark A.L., Lawton W.J., Abbound F.M., et al. Effects of high and low sodium intake on arterial pressure and forearm vascular resistance in borderline hypertension. Circ Res. 36:1975;194.
32. Tuck M.L. Role of salt in the control of blood pressure in obesity and diabetes mellitus. Hypertension. 17:(suppl I):1991;135.
33. Prineas R.J. Clinical interaction of salt and weight change on blood pressure level. Hypertension. 17:(suppl I):1991;143.
34. Staessen J., Bulpitt C.J., Fagard R., et al. Contraceptive pill use, urinary sodium and blood pressure. Acta Cardiol. 39:1984;55.
35. De La Sierra A., Lluch M.M., Pare J.C., et al. Increased left ventricular mass in salt-sensitive hypertensive patients. J Hum Hypertens. 10:1996;795.
36. Schmieder R.E., Lagenfeld M.R.W., Friedrich A., et al. Angiotensin II related to sodium excretion modulates left ventricular structure in human essential hypertension. Circulation. 89:1994;1304.
37. Jula A.M., Karank H.M. Effects on left ventricular hypertrophy of long-term nonpharmacological treatment with sodium restriction in mild to moderate essential hypertension. Circulation. 89:1994;1023.
38. Chrysant S.G., Walsh G.M., Kem D.C., Frohlich E.D. Hemodynamic and metabolic evidence of salt sensitivity in spontaneously hypertensive rats. Kidney Int. 15:1979;33.
39. Chrysant S.G., Mandal A.K., Nordquist J.A. Renal functional and organic changes induced by salt and prostaglandin inhibition in spontaneously hypertensive rats. Nephron. 25:1980;151.
40. Campese V.M., Pairse M., Karubian F., Bigazzi R. Abnormal renal hemodynamics in black salt sensitive patients with hypertension. Hypertension. 18:1991;805.
41. Weir M.R., Dengel D.R., Behrens M.T., Goldberg A.P. Salt-induced increases in systolic blood pressure affect renal hemodynamics and proteinuria. Hypertension. 25:1995;1339.
42. Alderman M.H., Madhaven S., Cohen H., et al. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension. 25:1995;1144.
43. Alderman M.H., Cohen H., Madhaven S. Dietary sodium intake and mortality. The National Health and Nutrition Examination Survey (NHANES 1). Lancet. 351:1998;781.
44. Kawasaki T., Delea C.S., Bartter F.C., Smith H. The effect of high-sodium and low sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension. Am J Med. 64:1978;193.
45. Brunner H.R., Laragh J.H., Baer L., et al. Essential hypertension renin and aldosterone, heart attack and stroke . N Engl J Med. 286:1972;441.
46. Alderman M.H., Madhaven S., Ooi W.L., et al. Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med. 324:1991;1098.
47. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med. 327:1991;685.
48. Ruppert M., Overlack A., Kolloch R., et al. Effects of severe and moderate salt restriction on serum lipids in nonobese normotensive adults. Am J Med Sci. 307:(suppl I):1994;587.
49. McCarron D.A., Weder A.B., Egan B.M., et al. Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients. Am J Hypertens. 10:1997;68.
50. Lind L., Lithell H., Gustafsson I.B., et al. Metabolic cardiovascular risk factors and sodium sensitivity in hypertensive subjects. Am J Hypertens. 5:1992;502.
51. Chrysant G.S., Bakir S., Oparil S. Dietary salt reduction in hypertension. What is the evidence and why is it still controversial? Prog Cardiovas Dis. 42:1999;23.
52. Chrysant S.G. Vascular remodeling the role of angiotensin-converting enzyme inhibitors . Am Heart J. 135:1998;S21.
53. Todd P.A., Fitton A. Peridopril a review of its pharmacological properties and therapeutic use in cardiovascular disorders . Drugs. 42:1991;90.
54. Chrysant S.G. Antihypertensive effects of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Arch Intern Med. 154:1994;737.
55. Chrysant S.G., Wombolt D.G., Feliciano N., Zheng H. Long-term efficacy and tolerability of valsartan and hydrochlorothiazide in patients with essential hypertension. Curr Ther Res. 56:1998;762.
56. McKelvie R.S., Yusuf S., Pericak D., et al. Comparison of candesartan, enalapril, and their combination in congestive heart failure. Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) Pilot Study investigators. Circulation. 100:1999;1056.
57. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med. 342:2000;145.
58. Chrysant SG, Weder AB, McCarron DA, et al. Effects of isradipine or enalapril on blood pressure in salt-sensitive hypertensives during low and high dietary salt intake. Am J Hypertens (in press).